Stockreport

Immunome gains 34% after preclinical data on COVID-19 antibody [Seeking Alpha]

Immunome, Inc.  (IMNM) 
PDF Immunome gains 34% after preclinical data on COVID-19 antibodyJun. 30, 2022 2:41 PM ETImmunome, Inc. ()By:Dulan LokuwithanaSA News EditorDr_Microbe/iStock via Getty Imag [Read more]